Artículos de revistas
Adjuvant Radiotherapy In Early Stage Endometrial Cancer [radioterapia Adjuvante Para Cǎncer Do Endométrio Estádio Inicial]
Registro en:
Revista Da Associacao Medica Brasileira. , v. 57, n. 4, p. 438 - 442, 2011.
1044230
10.1590/S0104-42302011000400019
2-s2.0-80052211621
Autor
Zuliani A.C.
Cairo A.A.
Esteves S.C.B.
dos Santos Watanabe C.C.
Cunha M.O.
de Souza G.A.
Institución
Resumen
Objective: To compare the rates of overall survival (OS), disease-free survival (DFS) and toxicity in different techniques of postoperative radiotherapy for stage IA endometrioid adenocarcinoma of endometrium, histological grades 1and 2. Methods: A historical comparison between treatment regimens was performed, and 133 women with a minimum follow-up of 5 years were included. Teletherapy (TELE group), with 22 patients treated from 1988 to 1996, with a 10 MV linear accelerator, average dose 46.2 Gy. Low dose rate brachytherapy (LDRB group) was performed between 1992 and 1995, in 19 women, with an insertion of Cesium 137, at a 60 Gy dose. Fourteen women operated between 1990 and 1996 did not receive radiotherapy (NO RT group). High dose rate brachytherapy was performed in 78 patients (HDRB group), from 1996 to 2004, in five weekly 7 Gy insertions, prescribed at 0.5 cm from the vaginal cylinder. Results: The 5-year disease-free survival was 94.6% for the HDRB group, 94.1% for the LDRB group, 100% for the TELE group and NO RT groups (p = 0.681). The 5-year overall survival was 86.6% for the HDRB group, 89.5% for the LDRB group and 90% for the TELE group and NO RT groups (p = 0.962). Grades 3-5 late toxicity was 5.3% in LDRB group and 27.3% for the TELE group (p < 0.001). Conclusion: Patients submitted to adjuvant teletherapy showed very high toxicity, which contraindicates that treatment for those patients. There may be a role for adjuvant HDRB, but randomized controlled trials are still needed to evaluate its benefit. © 2011 Elsevier Editora Ltda. 57 4 438 442 Pecorelli, S., Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium (2009) Int J Gynaecol Obstet, 105 (2), pp. 103-104. , Erratum in: Int J Gynaecol Obstet 2010;108(2):176 Greven, K.M., D'Agostino Jr., R.B., Lanciano, R.M., Corn, B.W., Is there a role for a brachytherapy vaginal cuff boost in the adjuvant management of patients withuterine-confined endometrial cancer? (1998) Int J RaDiat Oncol Biol Phys, 42 (1), pp. 101-104 Karolewski, K., Kojs, Z., Urbański, K., Jakubowicz, J., Blecharz, P., Dymek, P., The efficiency of treatment in patients with uterine-confined endometrial cancer (2006) Eur J Gynaecol Oncol, 27 (6), pp. 579-584 Cengiz, M., Singh, A.K., Grigsby, P.W., Postoperative vaginal brachytherapy aloneis the treatment of choice for grade 1-2, stage IC endometrial cancer (2005) Int J Gynecol Cancer, 15 (5), pp. 926-931 Lin, L.L., Mutch, D.G., Rader, J.S., Powell, M.A., Grigsby, P.W., External radiotherapy versus vaginal brachytherapy for patients with intermediate risk endometrial cancer (2007) Gynecol Oncol, 106 (1), pp. 215-220 Charra-Brunaud, C., Peiffert, D., Hoffstetter, S., Luporsi, E., Guillemin, F., Bey, P., Low-dose postoperative vaginal brachytherapy of adenocarcinoma of theendometrium (1998) Cancer Radiother, 2 (1), pp. 34-41 Piver, M.S., Hempling, R.E., A prospective trial of postoperative vaginal radium/cesium for grade 1-2 less than 50% myometrial invasion and pelvic radiation therapy for grade 3 or deep myometrial invasion in surgical stage Iendometrial adenocarcinoma (1990) Cancer, 66 (6), pp. 1133-1138 Straughn Jr., J.M., Huh, W.K., Kelly, F.J., Leath III, C.A., Kleinberg, M.J., Hyde Jr., J., Conservative management of stage I endometrial carcinoma after surgical staging (2002) Gynecol Oncol, 84 (2), pp. 194-200 Papanikolaou, A., Kalogiannidis, I., Goutzioulis, M., Misailidou, D., Makedos, A., Vergote, I., Pelvic lymphadenectomy as alternative to postoperative radiotherapy in high risk early stage endometrial cancer (2006) Arch Gynecol Obstet, 274 (2), pp. 91-96 Kong, A., Johnson, N., Cornes, P., Simera, I., Collingwood, M., Williams, C., Kitchener, H., Adjuvant radiotherapy for stage I endometrial cancer (2007) Cochrane Database Syst Rev, (2). , CD003916 Dale, R.G., The use of small fraction numbers in high dose-rate gynaecological afterloading: Some radiobiological considerations (1990) Br J Radiol, 63 (748), pp. 290-294 Cox, J.D., Stetz, J., Pajak, T.F., Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) (1995) Int J Radiat Oncol Biol Phys, 31 (5), pp. 134-146 Aalders, J., Abeler, V., Kolstad, P., Onsurd, M., Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: Clinical and histopathologic study of 540 patients (1980) Obstet Gynecol, 56 (4), pp. 419-427 Benedet, J.L., Bender, H., Jones III, H., Ngan, H.Y., Pecorelli, S., FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology (2000) Int J Gynaecol Obstet, 70 (2), pp. 209-262 Scholten, A.N., van Putten, W.L., Beerman, H., Smit, V.T., Koper, P.C., Lybeert, M.L., Postoperative radiotherapy for Stage 1 endometrial carcinoma: Long term outcome of the randomized PORTEC trial with central pathology review (2005) Int J Radiat Oncol Biol Phys, 63 (3), pp. 834-838 Creutzberg, C.L., van Putten, W.L., Koper, P.C., Lybeert, M.L., Jobsen, J.J., Wárlám-Rodenhuis, C.C., Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: Multicentre randomized trial. PORTEC Study Group. Post operative radiation therapy in endometrial carcinoma (2000) Lancet, 355 (9213), pp. 1404-1411 Keys, H.M., Roberts, J.A., Brunetto, V.L., Zaino, R.J., Spirtos, N.M., Bloss, J.D., A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: A Gynecologic Oncology Group study (2004) Gynecol Oncol, 92 (3), pp. 744-751 Lukka, H., Chambers, A., Fyles, A., Thephamongkhol, K., Fung-Kee-Fung, M., Elit, L., Adjuvant radiotherapy in women with stage I ndometrial cancer: A systematic review (2006) Gynecol Oncol, 102 (2), pp. 361-368 Kong, A., Powell, M., Blake, P., The role of postoperative radiotherapy in carcinoma of the endometrium (2008) Clin Oncol, 20 (6), pp. 457-462